Diagnostic and Interventional Cardiology

Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst

Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital

September 28, 2022 — A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are ...

September 28, 2022

Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valve—the first heart valve that can grow with the patient. Credit: Draper

News | Pediatric Cardiology

Draper Advances Growth-Adaptive Pediatric Heart Valve with Sutureless Adhesive

September 28, 2022 — Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before ...

September 28, 2022

George Washington University Researchers have found that post-stroke language and orientation impairments predicted recurrent stroke, while attention deficit impairment was associated with increased risk of death.

News | Stroke

New Study Provides Insights into Stroke Recurrence and Death in Patients with Insulin Resistance

September 28, 2022 — George Washington University researchers have found that post-stroke language and orientation ...

September 28, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Heart disease prevention pioneer Jeremiah Stamler, MD. Photo courtesy of Legacy.com

Feature | Cardiovascular Business | By Christine Book

Spotlight on Heart Disease Prevention Pioneer, Jeremiah Stamler, MD

World Heart Day takes place each year on September 29. Founded in 2000 by the World Heart Federation, World Heart Day ...

September 28, 2022

Martha Gulati, MD, is the new director of Preventive Cardiology in the Smidt Heart Institute. Photo by Cedars-Sinai.

News | Cardiovascular Business

Smidt Heart Institute Welcomes New Director of Preventive Cardiology

September 27, 2022 — Martha Gulati, MD, an expert in preventive cardiology and women’s heart disease, has joined the ...

September 27, 2022

Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups

News | Stents Bioresorbable

BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...

September 27, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the Heart Failure Society of America Annual Scientific Meeting in Washington, DC.

News | Cardiogenic Shock

Windtree Therapeutics Announces Istaroxime Late Breaker Abstract from its Positive Phase 2 Study in Early Cardiogenic Shock (SEISMiC) to be Presented at Heart Failure Society of America

September 27, 2022 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

September 27, 2022

Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.

News | Heart Valve Technology

Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval

September 26, 2022 — Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates ...

September 26, 2022

UC San Diego researchers have created the first diagnostic tool able differentiate between two similar pediatric inflammatory conditions, using a novel artificial intelligence-guided algorithm

News | Coronavirus (COVID-19)

How to Tell the Difference between Kawasaki Disease and MIS-C

September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed ...

September 26, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Evolut FX TAVR System Adds Innovative Features to Enhance Ease-of-Use and Predictable Valve Deployment

News | Structural Heart

Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

September 26, 2022 — Medtronic plc, a global leader in medical technology, announced U.S. Food and Drug Administration ...

September 26, 2022

Study of the Paradise Ultrasound Renal Denervation System Shows Significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension

News | Hypertension

ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the ...

September 26, 2022

Avicenna.AI are a medical imaging AI developer, optimizing radiologists’ manual tasks and identifying acute abnormalities. This partnership involves their stroke product suite, which enables automatic identification and triage for acute stroke.

News | Artificial Intelligence

Avicenna.AI Partners With deepc to Revolutionize Stroke Patient Care

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech ...

September 22, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.

News | Cardiogenic Shock

Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%

September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella ...

September 22, 2022

David J. Cohen, MD, MSc, St. Francis Hospital and CRF, presented Jennifer A. Rymer, MD, Duke University Medical Center with the TCT 2022 Thomas J. Linnemeier Young Investigator Award, along with co-presenter Gary S. Mintz of the Cardiovascular Research Foundation (CRF) on Sept 19 in Boston, MA.

News | TCT

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award

September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young ...

September 22, 2022

News | Stents Bifurcation

Medtronic Receives FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-eluting Stent

September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the ...

September 21, 2022